The professional staffing firm Kforce (NYSE:KFRC) reported fourth-quarter sales that edged past analyst expectations, yet its stock plunged 11.7% as earnings per share fell sharply short of estimates, highlighting ongoing challenges in a tightening labor market.
Shares of GE Vernova (GEV) have surged over 100% in the past year, closing near $726. As the energy transition play captivates the market, analysts are divided on whether its valuation still offers room to run or signals a peak.
As financial institutions grow more complex, a new report warns that their greatest vulnerabilities often lie not in unknown threats, but in systemic blind spots where accountability is diffused across multiple committees and functions.
Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.
The limited release of Google's world-building AI tool, Project Genie, has sent ripples through Wall Street and developer circles, reigniting debates about automation's role in creative industries.
Market momentum, technical indicators, and sustained capital inflows are aligning to potentially propel RAIN, KITE, and STABLE to new all-time highs in early February, though analysts caution over key resistance levels.
An AI-driven analysis suggests Cloudflare (NET) shares may face headwinds over the next two months, projecting an average price near $168. The forecast contrasts with bullish long-term analyst views, highlighting the tension between immediate technical signals and the company's strategic positioning in edge security and AI infrastructure.
Walt Disney Co. shares fell sharply Thursday following its Q1 2026 earnings report, as investor focus shifted from beating profit expectations to uncertainty surrounding CEO Bob Iger's successor and cautious guidance on park attendance.
T-Mobile has filed a WARN notice with Washington state officials, signaling permanent layoffs for 393 employees across multiple locations starting April 2026, amid a broader wave of tech sector workforce reductions.
The Bureau of Labor Statistics has postponed the release of January's crucial employment data due to a partial government shutdown, leaving markets and policymakers in the dark as a funding impasse in Congress continues.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
While a seven-figure nest egg is a common retirement goal, financial experts caution that its sufficiency hinges on withdrawal strategies, lifestyle expectations, and supplemental income.
Oracle's ambitious plan to raise up to $50 billion for AI infrastructure has triggered volatile swings in its share price, reflecting broader investor anxiety over the massive capital demands of the artificial intelligence arms race.
As economic anxieties mount, strategic diversification remains paramount. We examine two Vanguard ETFs that could offer stability and long-term growth opportunities should market conditions deteriorate.
TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
Despite recent sharp declines triggered by Fed nomination news, JPMorgan analysts reaffirm a bullish $6,300 per ounce gold target for 2026, citing resilient demand from central banks and investors.
The severe winter storm Fern, leaving nearly a million customers without power, has starkly highlighted the U.S. electrical grid's persistent vulnerabilities. This comes despite repeated warnings from reliability monitors about the system's growing strain.
Opera's stock surged following the announcement of expanded Tether (USDT and XAUT) integration in its MiniPay wallet, which processed over $153M in stablecoin transactions in December and aims to simplify crypto access for its 12.6 million users in emerging economies.
As Microsoft shares trade nearly 12% below recent highs, some analysts see a buying opportunity. We explore how selling put options could offer investors a strategic entry point while generating income.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
